Emergency department arrival times after acute ischemic stroke during the 1990s

Neurocritical Care

Volumn 7, Issue 1, 2007, Pages 31-35

  Kleindorfer, Dawn O ^a   Broderick, Joseph P ^a   Khoury, Jane ^a   Flaherty, Matthew L ^a   Woo, Daniel ^a   Alwell, Kathleen ^a   Moomaw, Charles J ^a   Pancioli, Arthur ^a   Jauch, Edward ^a   Miller, Rosie ^a   Kissela, Brett M ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Arrival times; Emergency department; Ischemic stroke

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; EMERGENCY SERVICE, HOSPITAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 36949007601     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-0029-5     Document Type: Article

References (15)

1. Reeves MJ, Arora S, Broderick JP, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005;36(6):1232-40.
2. Kleindorfer D SA, Kissela B, Woo D, Khoury J, Alwell K, Miller R, Gebel J, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Shukla R, Broderick JP. The effect of race and gender on patterns of rt-pa use within a population. J Stroke Cerebrovascular Diseases 2003;12(5):217-20.
3. Katzan IL, Furlan AJ LL, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the cleveland area experience. JAMA 2000;283(9):1151-8.
4. Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: the tll temple foundation stroke project. Stroke 2002;33(1):160-6.
5. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32(8):1832-40.
6. Kleindorfer D, Khoury J, Alwell K, et al. Eligibility for Rt-PA in Acute Ischemic Stroke: A Population-Based Study Stroke 2003;34(1):281.
7. Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke 2004;35(2):426-31.
8. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/ Northern Kentucky Stroke Study: preliminary first-ever total incidence rates of stroke among blacks. Stroke 1998;29:415-21.
9. NINDS Classification of neurological disorders III. Stroke 1990;21:637-76.
10. Brown R, Whisnant J, Sicks J, O'Fallon W, Wiebers D. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-80.
11. Brown RD, Jr Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke 1998;29(10):2109-13.
12. NINDS. Rapid identification and treatment of acute stroke. In: Marler JR, Jones PW, Emr M, editors. National symposium on rapid identification and treatment of acute stroke. Bethesda, Maryland: National Institutes of Health; 1997.
13. Author: California Acute Stroke Prototype Registry Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005;64(4):654-9.
14. Merino JG, Silver B, Wong E, et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002;33(1):141-6.
15. Fink J. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment. N Z Med J 2005;118(1214):U1430.